Canadian Glycomics Network: January 2017
Is this email not displaying correctly?
View this email in your browser
2017 Canadian Glycomics AGM & Symposium - Registration is Open!

GlycoNet Summer Awards Program 

Our Summer Awards program provides undergraduate students the opportunity to pursue summer research projects supervised by GlycoNet Network Investigators.

Funding is available. Hurry! Apply by February 1, 2017. Click here.

Last Call for Abstracts

Deadline: February 3, 2017.
For submission guidelines, click here.
GlycoNet researchers awarded US$600,000 grant from U.S. DoD for breast cancer project

Breast cancer is the most common cancer in women worldwide. In 2017, an estimated 300,000 women will be diagnosed with breast cancer in North America, with over 45,000 women expected to succumb to the disease. Despite impressive strides in cancer research, we are limited in our ability to predict which patients will experience deadly metastases, the spread of breast cancer, and our understanding of this process is lacking.

Recently, a team of researchers—Drs. Karla Williams, Ann Chambers, and two GlycoNet scientists Drs. Mark Nitz and Hon Leong—received a US$600,000 award from the U.S. Department of Defense (DoD) to expand their breast cancer research. Read more. 

Introducing a novel glycomics core service—the 48-hour molecular discovery

GlycoNet, in partnership with the Alberta Glycomics Centre (AGC) and the Derda Research Group at the University of Alberta, has launched its latest core service—the 48-Hour Discovery. This accelerated service is designed to help academia and industry in molecular discovery in the areas of therapeutics, diagnostics, and probe development.

“We bring expertise in molecular biology, informatics and biochemistry,” said GlycoNet and AGC investigator Dr. Ratmir Derda. Read more.

GlycoNet scientists attend first annual trilateral glycomics symposium

Glycomics, or the study of carbohydrates in biological systems, is experiencing a surge of activity due to the many ways in which carbohydrates impact human health. In December 2016, GlycoNet Scientific Director Dr. Todd Lowary and three GlycoNet scientists attended an International Union in Biochemistry and Molecular Biology (IUBMB)-sponsored symposium entitled “IUBMB Frontiers in Glycoscience: Host-pathogen Interactions” at Academia Sinica in Taipei, Taiwan. At the event, GlycoNet scientists—Drs. Sachiko Sato, Don Sheppard, and Chris Whitfield—delivered talks related to glycomics and antimicrobials. 

“The meeting and interactions were a tremendous success. It was a great opportunity to develop closer ties between the glycomics communities in Canada, Australia, and Taiwan,” Dr. Lowary said. “We are continuing to have discussions on further research collaborations between the three communities, with a particular focus on trainee research exchanges and core services.” Read more.

GlycoNet and the U of A’s CMASTE expand glycomics-related curricula

Recently, global initiatives within healthcare and science have focused on increasing carbohydrate research. Glycomics, or the study of the role of carbohydrates in biological processes, can help scientists unravel the complexities of many diseases that afflict humans.

This past summer, GlycoNet, in partnership with the University of Alberta’s Centre for Mathematics, Science, and Technology Education (CMASTE), recruited four teachers—two at the U of A to join the Derda Research Group, and two in the Quebec City area to work in Denis Giguère’s lab at l’Universite Laval.

Over several weeks, the teachers immersed themselves in the research labs, collaborating with GlycoNet principal investigators and lab members. Drawing on their experiences, the teachers established new connections between glycomics research and high school STEM curricula. Read more.

GlycoNet scientist to lead innovative study on treatment of periodontal disease

By Kimberly Elworthy

WATERLOO – Studies have shown problems with oral health are strong co-indicators of other serious diseases including diabetes, cancer and cardiovascular disease. In 2009, the cost associated with the treatment of periodontal disease was shown to be second only to cardiovascular disease in Canada.

A team of researchers at Wilfrid Laurier University, alongside researchers from McMaster and the University of Toronto, recently received funding from a GlycoNet Collaborative Team Grant to study innovative treatment options for periodontal diseases, specifically exploring ways to disrupt biofilm – such as plaque – to increase the effectiveness of treating harmful oral bacteria.

“To be recognized and funded by the federal government for research excellence puts Laurier in a strong position to create exciting research opportunities that will allow us to attract students and publish impactful research,” said Michael Suits, lead researcher on this project and an assistant professor in Laurier’s Department of Chemistry and Biochemistry. Read more.

GlycoNet Members in the News

Congratulations to all those recently published or making headlines!

Selected publications:

Summer Awards for Undergraduate Students 
Deadline: February 1, 2017 
The Summer Awards program provides undergraduate students the opportunity to pursue summer research projects supervised by GlycoNet Network Investigators. Learn More. Applications are submitted through the GlycoNet Forum.

SMRTS Series Webinar: Understanding Patents in the Academic Environment

Date: February 10, 2017 
Time: 11:00am - 12:00pm (MST)
Presented by: Lisa Sim - Partner, Miller Thomson LLP

This presentation will review the fundamentals of patent protection and the patent process in the context of commercializing innovation in the academic environment. Learn more.

We want to hear from you! 
Communicating your research findings is an important responsibility as a scientist. GlycoNet is here to support and promote communication of your research, but we need your help. Send photos, successes, milestones and information about awards and press coverage that you've received to
Forward this newsletter!
Copyright © 2017 Canadian Glycomics Network, All rights reserved.